Donate

Advocacy

Venezuela without insulin

Venezuela without insulin

This is for those of you who do not live in Venezuela, but need to know what’s happening in our country. Read more

Uninsured with diabetes in the USA

Uninsured with diabetes in the USA

I have had times of desperation where I have used expired insulin, skipped some meals and diluted my insulin with water until I could afford to buy my next vial, but I am alive. I would like to suggest a few things to those who are possibly facing a future with no insurance... Read more

A Letter to Congress

A Letter to Congress

I write to you today as a young American with serious concerns for the future of health care in this country, namely with the GOP’s proposed American Health Care Act (AHCA). My health situation forces a more elevated interest in the current health care debate compared to many of my young peers because I have type 1 diabetes. My fellow diabetics and I (who number around 30 million in the US) rely on access to affordable prescriptions and health care for our very survival. When I say my concerns are serious, I am not exaggerating. Read more

Mexico Needs More Diabetes Advocacy

Mexico Needs More Diabetes Advocacy

Just a few hours after World Diabetes Day the media in Mexico was frightening. According to the press, diabetes has become the number one cause of death in Mexico. We all know that it is actually the complications of diabetes, due to a lack of adequate treatments and insulin, that is killing our peers...
Read more

International Women's Day: Celebrating Sonia Nabeta

International Women's Day: Celebrating Sonia Nabeta

In the world of Type 1 diabetes (T1D), “warriors” are the valiant people living with this chronic condition. Sonia Nabeta was one such warrior, who for 16 years believed that her T1D diagnosis was a gift. Until her earthly candle was snuffed out in August 2015, she was convinced that T1D knocked on her door to sharpen attributes that otherwise would have lain dormant! She credited this ailment for many of her salient qualities, especially her diligence and discipline but most of all her compassion. Read more

The Cold Cost of American Capitalism

The Cold Cost of American Capitalism

My life is a roller coaster ride of uncertainty. I just want the tools I need to manage my life and to experience a semblance of happiness. Instead, I am squabbling with insurance and pharmaceutical companies to provide the care that I believe is my natural human right. The injustices experienced by type 1 diabetics in this country amount to a form of massacre. Read more

America is Number 1 - in Diabetes Costs

America is Number 1 - in Diabetes Costs

Everyone likes being #1, and Americans are no exception. Few Americans will be celebrating that they have the world’s highest out of pocket costs for insulin and other life-saving diabetes supplies. Read more

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more

T1International Year in Review: 2016

T1International Year in Review: 2016

What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more

Eli Lilly and Novo Nordisk: More Empty Promises

Eli Lilly and Novo Nordisk: More Empty Promises

Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more